|
Volumn 8, Issue 3, 2008, Pages 179-181
|
PI3K Enters Beta-Testing
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLATHRIN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
G PROTEIN COUPLED RECEPTOR;
GLUCOSE;
INSULIN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PROTEIN KINASE B;
PROTEIN P110;
PROTEIN TYROSINE KINASE;
RAB PROTEIN;
RAS PROTEIN;
TRANSCRIPTION FACTOR FOXO;
TRANSFERRIN;
CARCINOGENESIS;
CELL GROWTH;
CELL METABOLISM;
CELL PROLIFERATION;
CELL SURVIVAL;
DRUG TARGETING;
EMBRYO DEVELOPMENT;
ENDOCYTOSIS;
ENDOSOME;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
ENZYME REGULATION;
GLUCONEOGENESIS;
GLUCOSE INTOLERANCE;
GLUCOSE METABOLISM;
HUMAN;
LIVER PARENCHYMA;
MALIGNANT NEOPLASTIC DISEASE;
MALIGNANT TRANSFORMATION;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATIC INTRAEPITHELIAL NEOPLASIA;
PROTEIN DEPLETION;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN PHOSPHORYLATION;
SCIENTIFIC LITERATURE;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
1-PHOSPHATIDYLINOSITOL 3-KINASE;
ANIMALS;
CELL PROLIFERATION;
GLUCOSE;
HUMANS;
MODELS, BIOLOGICAL;
NEOPLASMS;
PROTEIN ISOFORMS;
RECEPTOR PROTEIN-TYROSINE KINASES;
|
EID: 50049105906
PISSN: 15504131
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cmet.2008.08.011 Document Type: Short Survey |
Times cited : (9)
|
References (12)
|